Sign In
Buy PFE
$25.69
+0.335 (+1.32%)
At Close: Jun 04, 2026
Is It Time to Invest in Pfizer? Exploring its 7% Dividend Yield and Growth Potential
06:44pm, Thursday, 19'th Jun 2025
Pfizer (NYSE:PFE) stock is a biopharmaceutical firm that had a magnificent breakout in 2021 as the worst of the pandemic sent COVID vaccine demand through the roof.
Pfizer Boasts Strong Oncology Portfolio: Can it Sustain Growth?
10:51am, Thursday, 19'th Jun 2025
PFE's oncology portfolio, boosted by Seagen and late-stage pipeline assets, may fuel growth amid lackluster stock performance.
RFK Jr weighs review of vaccines citing aluminum use, Bloomberg News reports
01:05pm, Wednesday, 18'th Jun 2025
U.S. Health Secretary Robert F. Kennedy Jr. is considering asking a key government vaccine advisory panel to examine vaccines that contain aluminum ingredients, Bloomberg News reported on Wednesday, c
RFK Jr.'s new vaccine advisors will vote on flu shots containing mercury
01:01pm, Wednesday, 18'th Jun 2025
A revamped government panel of vaccine advisors appointed by Health and Human Services Secretary Robert F. Kennedy Jr. will soon vote on a shot preservative that contains mercury, which is safely used
3 High-Yield Dividend Stocks Increasing Payouts For Decades
09:42am, Wednesday, 18'th Jun 2025
These dividend stocks have high yields and solid upside potential. They also have quality underlying businesses.
50% Off - 2 Dividend Gems With Huge Income And Growth Potential
07:30am, Wednesday, 18'th Jun 2025
Investing capital means balancing risk, goals, and timing, especially when markets face uncertainty and shifting global dynamics. I focus on long-term value and income. I highlight two undervalued opp
2 Top Stocks to Buy With Less Than $30
07:00am, Wednesday, 18'th Jun 2025
Though wealthy and successful investors garner much attention on Wall Street, equity markets are accessible to the average person. That's one of the great things about investing in stocks.
Should Value Investors Buy Pfizer (PFE) Stock?
10:41am, Tuesday, 17'th Jun 2025
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
5 Low Price-to-Book Value Stocks That You Can Buy in June
10:05am, Tuesday, 17'th Jun 2025
The P/B ratio helps to identify low-priced stocks with high growth prospects. USNA, CVS, PFE, STNE and PSFE are some such stocks.
Why I Just Bought More of This Beaten-Down 7%-Yielding Dividend Stock
04:49am, Tuesday, 17'th Jun 2025
Pick a time frame -- year to date, last 12 months, last three years, last five years, or last 10 years. Regardless of which you choose, Pfizer's (PFE -0.63%) share price has declined during the period
PFE or LLY: Which Is the Better Value Stock Right Now?
12:41pm, Monday, 16'th Jun 2025
Investors interested in stocks from the Large Cap Pharmaceuticals sector have probably already heard of Pfizer (PFE) and Eli Lilly (LLY). But which of these two stocks is more attractive to value inve
4 Value Stocks to Shield Your Portfolio Amid Geopolitical Turmoil
10:31am, Monday, 16'th Jun 2025
As geopolitical risks jolt markets, STNE, CNC, CVS and PFE shine with low cash flow valuations and solid earnings outlooks.
5 Large Drug Stocks That Are Poised to Ride on Sector Recovery
10:11am, Monday, 16'th Jun 2025
In the Large-Cap Pharmaceuticals industry, AbbVie, Novartis, Pfizer, Sanofi and Bayer are worth retaining amid macro pressure and rising innovation.
Two Alternatives For A Potential $5000 Monthly Income
08:05am, Saturday, 14'th Jun 2025
Traditionally, a large portion of equity returns has come from two factors - reinvested dividends and compounding. We present two income-focused approaches: a fund-based portfolio for hands-off invest
INVESTIGATION ALERT: Berger Montague PC Investigates Pfizer Inc.'s Board Of Directors For Breach of Fiduciary Duties (NYSE: PFE)
03:11pm, Thursday, 12'th Jun 2025
PHILADELPHIA, June 12, 2025 (GLOBE NEWSWIRE) -- Berger Montague advises shareholders of Pfizer Inc. (“Pfizer” or the “Company”) (NYSE: PFE) about an investigation into Pfizer's Board of Direct
